Guidelines for the management of community-acquired pneumonia in children

Acta Paediatrica Taiwanica

Volumn 48, Issue 4, 2007, Pages 167-180

  Lee, Ping Ing ^a   Chiu, Cheng Hsun ^b   Chen, Po Yen ^c   Lee, Chin Yun ^a   Lin, Tzou Yien ^b,d   Lu, Frank Leigh ^d   Huang, Li Min ^d   Hsieh, Wu Shiun ^d   Tang, Ren Bin ^d   Soong, Wen Jue ^d   Wang, Chih Chien ^d   Huang, Fu Yuan ^d   Lien, Rey In ^d   Huang, Yhu Chering ^d   Wong, Kin Sun ^d   Liu, Ching Chuan ^d   Hwang, Kao Pin ^d   Lin, Yung Zen ^d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; C REACTIVE PROTEIN; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CLARITHROMYCIN; ERYTHROMYCIN; IMIPENEM; MEROPENEM; OXACILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TIMENTIN;

BACTERIAL PNEUMONIA; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG TOLERABILITY; FLUID THERAPY; HOSPITALIZATION; HUMAN; INFLUENZA VIRUS; LABORATORY TEST; LUNG BIOPSY; LUNG LAVAGE; MYCOBACTERIUM TUBERCULOSIS; OXYGEN THERAPY; PRACTICE GUIDELINE; RECOMMENDED DRUG DOSE; REVIEW; THORAX RADIOGRAPHY; TREATMENT DURATION; VIRUS INFECTION;

ANTI-BACTERIAL AGENTS; CHILD; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; PNEUMONIA, BACTERIAL; PRACTICE GUIDELINES AS TOPIC;

EID: 37549057043     PISSN: 16088115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Isaacs D. Problems in determining the etiology of community-acquired childhood pneumonia. Pediatr Infect Dis J 1989; 8:143-8.
2. Huang YC, Lin TY, Chang LY, Wong KS, Ning SC. Epidemiology of respiratory syncytial virus infection among paediatric inpatients in northern Taiwan. Eur J Pediatr 2001; 160:581-2.
3. Lin TY, Huang YC, Ning HC, Tsao KC. Surveillance of respiratory viral infections among pediatric outpatients in northern Taiwan. J Clin Virol 2004; 30:81-5.
4. Chen CJ, Jeng MJ, Yuan HC, Wu KG, Soong WJ, Hwang B. Epidemiology of respiratory syncytial virus in children with respiratory tract infection. Acta Paediatr Taiwan 2005; 46:72-6.
5. Chuang YY, Chiu CH, Wong KS, et al. Severe adenovirus infection in children. J Microbiol Immunol Infect 2003; 36:37-40.
6. Lee PI, Wu MH, Huang LM, Chen JM, Lee CY. An open, randomized, comparative study of clarithromycin and erythromycin in the treatment of children with community-acquired pneumonia. J Microbiol Immunol Infect 2007 (in press).
7. Ngeow YF, Suwanjutha S, Chantarojanasriri T, et al. An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia. Intern J Infect Dis 2005; 9:144-53.
8. Chiang YC, Shyur SD, Huang LH, et al. Chlamydia trachomatis pneumonia: experience in a medical center. Acta Paediatr Taiwan 2005; 46:284-8.
9. Wang CH, Lin TY. Invasive Haemophilus influenzae diseases and purulent meningitis in Taiwan. J Formos Med Assoc 1996; 95:599-604.
10. Schultz KD, Fan LL, Pinsky J, et al. The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 2004; 113:1735-40.
11. Alfaro C, Fergie J, Purcell K. Emergence of community-acquired methicillin-resistant Staphylococcus aureus in complicated parapneumonic effusions. Pediatr Infect Dis J 2005; 24:274-76.
12. Fang YH, Hsueh PR, Hu JJ, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children in northern Taiwan. J Microbiol Immunol Infect 2004; 37:29-34.
13. Chen CJ, Huang YC, Chiu CH, Su LH, Lin TY. Clinical features and genotyping analysis of community-acquired methicillin-resistant Staphylococcus aureus infections in Taiwanese children. Pediatr Infect Dis J 2005; 24:40-5.
14. Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005; 353:2559-67.
15. Lin YS, Huang YC, Chang LY, Lin TY, Wong KS. Clinical characteristics of tuberculosis in children in the north of Taiwan. J Microbiol Immunol Infect 2005; 38:41-6.
16. Palafox M, Guiscafre H, Reyes H, et al. Diagnostic value of tachypnea in pneumonia defined radiologically. Arch Dis Child 2000; 82:41-5.
17. Pereira JC, Escuder MM. The importance of clinical symptoms and signs in the diagnosis of community-acquired pneumonia. J Trop Pediatr 1998; 44:18-24.
18. British Thoracic Society of Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in childhood. Thorax 2002; 57:1-24.
19. Aujesky D, Auble TE, Yealy DM, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 2005; 118:384-92.
20. Capelastegui A, Espana PP, Quintana JM, et al. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J 2006; 27:151-7.
21. Ramsey BW, Marcuse EK, Foy HM, et al. Use of bacterial antigen detection in the diagnosis of pediatric lower respiratory tract infections. Pediatrics 1986; 78:1-9.
22. Turner RB, Lande AE, Chase P, Hilton N, Weinberg D. Pneumonia in pediatric outpatients: cause and clinical manifestations. J Pediatr 1987; 111:194-200.
23. Forgie IM, O'Neill KP, Lloyd-Evans N, et al. Etiology of acute lower respiratory tract infections in Gambian children. I. Acute lower respiratory tract infections in infants presenting at the hospital. Pediatr Infect Dis J 1991; 10:33-41.
24. Heiskanen-Kosma T, Korppi M. Serum C-reactive protein cannot differentiate bacterial and viral aetiology of community-acquired pneumonia in children in primary healthcare settings. Scand J Infect Dis 2000; 32:399-402.
25. Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993; 91:1351-7.
26. Swingler GH, Hussey GD, Zwarenstein M. Randomised controlled trial of clinical outcome after chest radiograph in ambulatory actue lower-respiratory infection in children. Lancet 1998; 351:404-8.
27. Bachur R, Perry H, Harper MB. Occult penumonias: empiric chest radiographs in febrile children with leukocytosis. Ann Emerg Med 1999; 33:166-73.
28. Korvick JA, Hackett AK, Yu VL, Muder RR. Klebsiella pneumonia in the modern era: clinicoradiographic correlations. South Med J 1991; 84:200-4.
29. Francis JB, Francis PB. Bulging (sagging) fissure sign in Hemophilus influenzae lobar pneumonia. S Med J 1978; 71:1452-3.
30. Syrjala H, Broas M, Suramo I, et al. High-resolution computerized tomography for the diagnosis of community-acquired pneumonia. Clin Infect Dis 1998; 27:358-63.
31. Voss LM. Management of tuberculosis in children. J Paediatr Child Health 2000; 36:530-6.
32. Mandell LA, Marrie TJ, Grossman RF, et al. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000; 31:383-421.
33. Su HP, Tseng LR, Chou CY, Chung TC, Pan TM. Legionella pneumophila infection in the Taiwan area. J Infect Chemother 2005; 11:244-9.
34. Dominguez J, Galí N, Blanco S, et al. Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples. Chest 2001; 119:243-9.
35. Murdoch DR, Laing RT, Mills GD, et al. Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia. J Clin Microbiol 2001; 39:3495-8.
36. Navarro D, Garcia-Maset L, Gimeno C, Escribano A, Garcia-de-Lomas J, Spanish Pneumococcal Infection Study Network. Performance of the Binax NOW Streptococcus pneumoniae urinary antigen assay for diagnosis of pneumonia in children with underlying pulmonary diseases in the absence of acute pneumococcal infection. J Clin Microbiol 2004; 42:4853-5.
37. Dowell SF, Garman RL, Liu G, Levine OS, Yang YH. Evaluation of Binax NOW, an assay for the detection of pneumococcal antigen in urine samples, performed among pediatric patients. Clin Infect Dis 2001; 32:824-5.
38. Ramsey BW, Marcuse EK, Foy HM, et al. Use of bacterial antigen detection in the diagnosis of pediatric lower respiratory tract infections. Pediatrics 1986; 78:1-9.
39. Bowerman RJ. Tuberculin skin testing in BCG-vaccinated populations of adults and children at high risk for tuberculosis in Taiwan. Int J Tuberc Lung Dis 2004; 8:1228-33.
40. Munoz FM, Starke JR. Tuberculosis (Mycobacterium tuberculosis). In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 17th ed. Philadelphia: Churchill Saunders, 2004:958-72.
41. Light RW, Girard WM, Jenkinson SG, et al. Parapneumonic effusions. Am J Med 1980; 69:507-12.
42. Requejo HI, Guerra ML, Dos Santos M, et al. Immunodiagnoses of community-acquired pneumonia in childhood. J Trop Paediatr 1997; 43:208-12.
43. Scheinmann P. Berche P. Ferroni A, et al. Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids. Clin Infect Dis 2006; 42:1135-40.
44. Smyth A, Carty H, Hart CA. Clinical predictors of hypoxaemia in children with pneumonia. Ann Trop Paediatr 1998; 18:31-40.
45. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process and outcomes in elderly patients with pneumonia. J Am Med Assoc 1997; 278:2080-4
46. Houck PM, Bratzler DW, Nsa W, Ma A, Barlett JG. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with pneumonia. Arch Intern Med 2004; 164:637-44.
47. Lee PI, Lee CY, Chen JM, Huang LM, Hwang KC, Lee MJ. Efficacy and safety of oral cefixime therapy in common infectious diseases in children. Acta Paediatr Taiwan 1991; 32:145-150.
48. Huang YC, Lin TY, Wang CH. Community-acquired Pseudomonas aeruginosa sepsis in previously healthy infants and children: analysis of forty-three episodes. Pediatr Infect Dis J 2002; 21:1049-52.
49. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibotic therapy for ventilator-associated pneumonia in adults: a randomized trial. J Am Med Assoc 2003; 290:2588-98.
50. Hsieh YC, Hsueh PR, Lu CY, Lee PI, Lee CY, Huang LM. Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused by Streptococcus pneumoniae in children in Taiwan. Clin Infect Dis 2004; 38:830-5.
51. Anonymous. Guidelines on antimicrobial therapy of pneumonia in Taiwan. The Infectious Diseases Society of the Republic of China. J Microbiol Immunol Infect 1999; 32:292-4.
52. Hsueh PR. Decreasing rates of resistance to penicillin, but not erythromycin, Streptococcus pneumniae after introduction of a policy to restrict antibiotic usage in Taiwan. Clin Mircobiol Infect 2005; 11:925-7.
53. Hsueh PR, Liu YC, Shyr JM, et al. Multicenter surveillance of antimicrobial resistance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan during the 1998-1999 respiratory season. Antimicrob Agents Chemother 2000; 44:1342-5.
54. Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 2006; 12:984-9.
55. Mandell LA, Barlett JG, Dowell SF, File TM, Musher DM, Whitney C. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003; 37:1405-33.
56. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730-54.
57. Mufson MA, Stanek RJ. Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978-1997. Am J Med 1999; 107(Suppl 1):S34-S43.
58. Martinez JA, Horcajada JP, Almeld M, et al. Addition of a macrolide to a β-lactam based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2003; 36:396-8.
59. Craig WA. Re-evaluating current antibiotic therapy. Respir Med 2001; 95(Suppl A):S12-S19.
60. Schlossberg D. Clinical approach to antibiotic failure. Med Clin N Am 2006; 90:1265-77.
61. Cunha BA. Antibiotic side effects. Med Clin N Am 2001; 85:149-85.
62. Oizumi K. Onuma K. Watanabe A. Motomiya M. Clinical study of drug fever induced by parenteral administration of antibiotics. Tohoku J Exp Med 1989; 159:45-56.
63. Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 2000; 118:1158-71.
64. Kocijancic I, Vidmar K, Ivanovi-Herceg Z. Chest sonography versus lateral decubitus radiography in the diagnosis of small pleural effusions. J Clin Ultrasound 2003; 31:69-74.
65. Requejo HI, Guerra ML, Dos Santos M, Cocozza AM. Immunodiagnoses of community-acquired pneumonia in childhood. J Trop Pediatr 1997; 43:208-12.
66. Le Monnier A, Carbonnelle E, Zahar JR, et al. Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids. Clin Infect Dis 2006; 42:1135-40.
67. Heffner JE, Brown LK, Barbieri C, DeLeo JM. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Resipir Crit Care Med 1995; 151:1700-8.
68. Yao CT, Wu JM, Liu CC, Wu MH, Chuang HY, Wang JN. Treatment of complicated parapneumonic pleural effusion with intrapleural streptokinase in children. Chest 2004; 125:566-71.
69. Chen JP, Lue KH, Liu SC, Cheng SL, Sheu JN. Intrapleural urokinase treatment in children with complicated parapneumonic effusion. Acta Paediatr Taiwan 2006; 47:61-6.
70. Kalfa N, Allal H, Lopez M, et al. Thoracoscopy in pediatric pleural empyema: a prospective study of prognostic factors. J Pediatr Surg 2006; 41:1732-7.
71. Waller DA, Rengarajan A, Nicholson FHG, Rajesh PB. Delayed referral reduces the success of video-assisted thoracoscopic debridement for post-pneumonic empyema. Respir Med 2001; 95:836-40.
72. Kalfa N, Allal H, Montes-Tapia F, et al. Ideal timing of thoracoscopic decortication and drainage for empyema in children. Surg Endosc 2004; 18:472-7.
73. Madhi SA, Klugman KP, the Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 2004; 10:811-3.
74. Smith NM, Bresee JS, Shay DK, et al. Prevention and Control of Influenza. Recommendation of the Advisory Committee on Immunization Practices. Morb Mortal Wkly Rep 2006; 55(RR10):1-42.
75. Overturf GD. American Academy of Pediatrics. Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics 2000; 106(2 Pt 1):367-76.